These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11158030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.
    De Bellis A, Bizzarro A, Rossi R, Paglionico VA, Criscuolo T, Lombardi G, Bellastella A.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1002-7. PubMed ID: 8473373
    [Abstract] [Full Text] [Related]

  • 3. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
    Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, Sanzari M, Tedesco F, Pedini B, Boscaro M, Presotto F.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
    [Abstract] [Full Text] [Related]

  • 4. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
    Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, Greggio NA, Pedini B, Boscaro M, Presotto F.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
    [Abstract] [Full Text] [Related]

  • 5. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.
    Laureti S, De Bellis A, Muccitelli VI, Calcinaro F, Bizzarro A, Rossi R, Bellastella A, Santeusanio F, Falorni A.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3507-11. PubMed ID: 9768655
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.
    Silva RC, Sallorenzo C, Kater CE, Dib SA, Falorni A.
    Diabetes Nutr Metab; 2003 Jun; 16(3):160-8. PubMed ID: 14635733
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
    de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A.
    Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
    [Abstract] [Full Text] [Related]

  • 9. The natural history of autoimmune Addison's disease with a non-classical presentation: a case report and review of literature.
    Manso J, Pezzani R, Scarpa R, Gallo N, Betterle C.
    Clin Chem Lab Med; 2018 May 24; 56(6):896-900. PubMed ID: 29478039
    [Abstract] [Full Text] [Related]

  • 10. Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo.
    Boscaro M, Betterle C, Volpato M, Fallo F, Furmaniak J, Rees Smith B, Sonino N.
    J Clin Endocrinol Metab; 1996 Aug 24; 81(8):2801-4. PubMed ID: 8768833
    [Abstract] [Full Text] [Related]

  • 11. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
    Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C.
    J Clin Endocrinol Metab; 2006 May 24; 91(5):1637-45. PubMed ID: 16522688
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
    Betterle C, Volpato M, Pedini B, Chen S, Smith BR, Furmaniak J.
    J Clin Endocrinol Metab; 1999 Feb 24; 84(2):618-22. PubMed ID: 10022426
    [Abstract] [Full Text] [Related]

  • 19. [Subclinical adrenal diseases: silent pheochromocytoma and subclinical Addison's disease].
    Thuillier P, Kerlan V.
    Ann Endocrinol (Paris); 2012 Oct 24; 73 Suppl 1():S45-54. PubMed ID: 23089381
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.